BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19966810)

  • 1. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.
    Barlow JL; Drynan LF; Hewett DR; Holmes LR; Lorenzo-Abalde S; Lane AL; Jolin HE; Pannell R; Middleton AJ; Wong SH; Warren AJ; Wainscoat JS; Boultwood J; McKenzie AN
    Nat Med; 2010 Jan; 16(1):59-66. PubMed ID: 19966810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5q- syndrome.
    Boultwood J; Pellagatti A; Wainscoat JS
    Curr Pharm Des; 2012; 18(22):3180-3. PubMed ID: 22571696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the 5q- syndrome.
    Boultwood J; Pellagatti A; McKenzie AN; Wainscoat JS
    Blood; 2010 Dec; 116(26):5803-11. PubMed ID: 20733155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.
    Dutt S; Narla A; Lin K; Mullally A; Abayasekara N; Megerdichian C; Wilson FH; Currie T; Khanna-Gupta A; Berliner N; Kutok JL; Ebert BL
    Blood; 2011 Mar; 117(9):2567-76. PubMed ID: 21068437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dissection of the 5q deletion in myelodysplastic syndrome.
    Ebert BL
    Semin Oncol; 2011 Oct; 38(5):621-6. PubMed ID: 21943668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Zebrafish Model of 5q-Syndrome Using CRISPR/Cas9 Targeting RPS14 Reveals a p53-Independent and p53-Dependent Mechanism of Erythroid Failure.
    Ear J; Hsueh J; Nguyen M; Zhang Q; Sung V; Chopra R; Sakamoto KM; Lin S
    J Genet Genomics; 2016 May; 43(5):307-18. PubMed ID: 27216296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.
    Schneider RK; Schenone M; Ferreira MV; Kramann R; Joyce CE; Hartigan C; Beier F; Brümmendorf TH; Germing U; Platzbecker U; Büsche G; Knüchel R; Chen MC; Waters CS; Chen E; Chu LP; Novina CD; Lindsley RC; Carr SA; Ebert BL
    Nat Med; 2016 Mar; 22(3):288-97. PubMed ID: 26878232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closing in on the pathogenesis of the 5q- syndrome.
    Post SM; Quintás-Cardama A
    Expert Rev Anticancer Ther; 2010 May; 10(5):655-8. PubMed ID: 20469997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.
    Kumar MS; Narla A; Nonami A; Mullally A; Dimitrova N; Ball B; McAuley JR; Poveromo L; Kutok JL; Galili N; Raza A; Attar E; Gilliland DG; Jacks T; Ebert BL
    Blood; 2011 Oct; 118(17):4666-73. PubMed ID: 21873545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.
    Neuwirtova R; Fuchs O; Holicka M; Vostry M; Kostecka A; Hajkova H; Jonasova A; Cermak J; Cmejla R; Pospisilova D; Belickova M; Siskova M; Hochova I; Vondrakova J; Sponerova D; Kadlckova E; Novakova L; Brezinova J; Michalova K
    Ann Hematol; 2013 Jan; 92(1):11-8. PubMed ID: 22965552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.
    Bereshchenko O; Lo Re O; Nikulenkov F; Flamini S; Kotaskova J; Mazza T; Le Pannérer MM; Buschbeck M; Giallongo C; Palumbo G; Li Volti G; Pazienza V; Cervinek L; Riccardi C; Krejci L; Pospisilova S; Stewart AF; Vinciguerra M
    Clin Epigenetics; 2019 Aug; 11(1):121. PubMed ID: 31439048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome.
    Boultwood J
    Pediatr Rep; 2011 Jun; 3 Suppl 2(Suppl 2):e10. PubMed ID: 22053272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome.
    Ribezzo F; Snoeren IAM; Ziegler S; Stoelben J; Olofsen PA; Henic A; Ferreira MV; Chen S; Stalmann USA; Buesche G; Hoogenboezem RM; Kramann R; Platzbecker U; Raaijmakers MHGP; Ebert BL; Schneider RK
    Leukemia; 2019 Jul; 33(7):1759-1772. PubMed ID: 30651631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency of Apc leads to ineffective hematopoiesis.
    Wang J; Fernald AA; Anastasi J; Le Beau MM; Qian Z
    Blood; 2010 Apr; 115(17):3481-8. PubMed ID: 20065296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyserythropoiesis of myelodysplastic syndromes.
    Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
    Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into 5q- syndrome as a ribosomopathy.
    Barlow JL; Drynan LF; Trim NL; Erber WN; Warren AJ; McKenzie AN
    Cell Cycle; 2010 Nov; 9(21):4286-93. PubMed ID: 20980806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion 5q MDS: molecular and therapeutic implications.
    Komrokji RS; Padron E; Ebert BL; List AF
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells.
    Butler C; Dunmire M; Choi J; Szalai G; Johnson A; Lei W; Chen X; Liu L; Li W; Walter MJ; Liu T
    Cell Stress Chaperones; 2024 Apr; 29(2):300-311. PubMed ID: 38508444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
    Fernandez-Mercado M; Burns A; Pellagatti A; Giagounidis A; Germing U; Agirre X; Prosper F; Aul C; Killick S; Wainscoat JS; Schuh A; Boultwood J
    Haematologica; 2013 Dec; 98(12):1856-64. PubMed ID: 23831921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion.
    Ximeri M; Galanopoulos A; Klaus M; Parcharidou A; Giannikou K; Psyllaki M; Symeonidis A; Pappa V; Kartasis Z; Liapi D; Hatzimichael E; Kokoris S; Korkolopoulou P; Sambani C; Pontikoglou C; Papadaki HA;
    Haematologica; 2010 Mar; 95(3):406-14. PubMed ID: 19773257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.